glp-1 suicidal thoughts US FDA removes warning from weight-loss drugs US FDA requests removal of

Glucagon-like peptide-1 is a hormone produced in the gut that travels through the bloodstream and attaches to a receptor found on the surface of cells mostly in the pancreas and the brain

Safety and efficacy of glucagon-like peptide-1 receptor agonists in children and adolescents with obesity: a meta-analysis

benefit analysis in long-term therapy DPP-4 inhibitors are a safe and well-tolerated drug class, ideal for older adults, type 2 diabetes patients, and those with kidney manifestations

The bottom line Orforglipron is one of the most exciting developments in weight loss treatment in recent years

[11] SELECT : SELECT was a large randomized, controlled trial that enrolled over 17,000 adults with established cardiovascular disease, an elevated BMI, but no diabetes